Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CTSV | O60911 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21617165 | 1.00 | MAOB (0.46) | MAOBMAOACHRM4BRD4SGMS2 | |
| SCHEMBL31504389 | 0.90 | MAOB (0.47) | MAOBMAOACHRM4BRD4SGMS2 | |
| SCHEMBL21617188 | 0.90 | MAOB (0.47) | MAOBMAOACHRM4BRD4SGMS2 | |
| SCHEMBL21617306 | 0.87 | MAOB (0.46) | MAOBMAOACHRM4BRD4SGMS2 | |
| SCHEMBL31504451 | 0.87 | MAOB (0.46) | MAOBMAOACHRM4BRD4SGMS2 | |
| SCHEMBL21617278 | 0.84 | SIRT2 (0.58) | MAOBMAOACHRM4SGMS2KMT2A | |
| SCHEMBL31504450 | 0.84 | SIRT2 (0.58) | MAOBMAOACHRM4SGMS2KMT2A | |
| SCHEMBL21617297 | 0.82 | SGMS2 (0.43) | MAOBMAOACHRM4SGMS2MEN1 | |
| SCHEMBL31504359 | 0.82 | SGMS2 (0.43) | MAOBMAOACHRM4SGMS2MEN1 | |
| SCHEMBL21617230 | 0.81 | CTSV (0.62) | MAOBCHRM4MEN1KMT2ACTSV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3820850-B1 | PHENYL/PYRIDYL-N-PHENYL/PYRIDYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION | ABIVAX (FR) | 2026-04-01 | — | — | EP | disclosed |
| CN-112638877-B | Phenyl/pyridinyl-N-phenyl/pyridinyl derivatives for the treatment of RNA viral infections | ABIVAX公司 | 2025-04-22 | — | — | CN | disclosed |